Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Rybelsus is approved along with a diet and exercise plan to manage blood sugar levels and type 2 diabetes. Some people use it off-label for weight loss. Limiting overly processed foods ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Learn how to get Rybelsus. PlushCare is a telehealth platform offering virtual primary care visits, access to diabetes specialists, and doctor-led weight loss programs. Unlike many other online ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Other brand names for semaglutide you might have heard of include Wegovy (a higher-dose semaglutide injection FDA-approved for weight loss) and Rybelsus (a tablet form of semaglutide FDA-approved ...